Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Best Dividend Kings: August 2025
10:13pm, Sunday, 24'th Aug 2025
Dividend Kings underperformed SPY year-to-date but are showing stronger gains in August, with several stocks achieving double-digit returns in 2025. Fifteen Dividend Kings currently appear undervalued
2 Dividend Stocks Worth Doubling Down on Right Now
11:14am, Sunday, 24'th Aug 2025
Dividend stocks aren't all created equal. Some decrease their payouts, or suspend them altogether, when they face headwinds.
Johnson & Johnson to invest $2B in North Carolina plant as Trump's 250% drug tariffs loom
05:34pm, Friday, 22'nd Aug 2025
It's a move to boost its domestic production as President Donald Trump threatens to slap devastating tariffs on pharmaceutical imports.
Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now
12:46pm, Friday, 22'nd Aug 2025
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
4 Medical Devices Behemoths to Buy Amid Extensive AI Applications
09:06am, Friday, 22'nd Aug 2025
AI-driven innovations in medical devices are fueling growth for BSX, JNJ, GEHC and TEM.
3 Stable Dividend-Paying Stocks That Are Perfect for Retirees
06:32pm, Thursday, 21'st Aug 2025
For retirees seeking income, dividend investing is less about chasing the highest yield and more about owning stocks that reliably generate cash and consistently increase their payouts. Add in stabili
Johnson & Johnson announces $2 billion investment to boost U.S. manufacturing as tariffs loom
11:41am, Thursday, 21'st Aug 2025
Johnson & Johnson said on Thursday it would invest $2 billion in North Carolina as it aims to expand its U.S. manufacturing presence amid looming drug import duties proposed by President Donald Trump'
Can J&J Navigate Stelara, Talc Suits, Tariff & Other Headwinds?
10:21am, Thursday, 21'st Aug 2025
J&J battles Stelara losses, talc lawsuits, tariffs and China headwinds while banking on growth plans and new launches to stay resilient.
Johnson & Johnson to invest $2 billion in North Carolina to boost US manufacturing
05:11am, Thursday, 21'st Aug 2025
Johnson & Johnson on Thursday committed to invest $2 billion in North Carolina to expand the drugmaker's U.S. manufacturing presence.
2 unstoppable dividend stocks to buy now
04:55am, Wednesday, 20'th Aug 2025
For long-term investors, dividend-paying companies remain a key factor as they provide both income and stability.
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
10:01am, Monday, 18'th Aug 2025
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm
07:23pm, Sunday, 17'th Aug 2025
Pharmaceutical companies regularly encounter substantial headwinds. Among the most significant are patent cliffs -- when therapies lose patent exclusivity, inviting cheaper generic or biosimilar compe
These Are the 3 Smartest Dividend Stocks Today
10:30am, Saturday, 16'th Aug 2025
You can't time the market, but you can bank on a good dividend. Especially when stocks are swinging in volatile times, reliable income is a rare anchor.
Why Is Johnson & Johnson (JNJ) Up 7.2% Since Last Earnings Report?
12:31pm, Friday, 15'th Aug 2025
Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock?
Back To Basics: Why I Favor Amgen Over Johnson & Johnson
03:06pm, Thursday, 14'th Aug 2025
Both Amgen (AMGN) and Johnson & Johnson (JNJ) recently received a 60-day ultimatum to lower their prices in the U.S. market. A fundamental analysis shows AMGN to be better positioned than JNJ to absor
